Pharmacist Charged With Drug Diversion From National Pharmacy Chain
BOSTON – A Pittsfield pharmacist has been charged in federal court in Boston with allegedly diverting Adderall and Dextroamp-amphetamin (generic Adderall) from a national pharmacy chain.
Joshua Bradley, 30, of Pittsfield, was charged with five counts of acquiring a controlled substance by fraud, deception and subterfuge. The defendant will make an initial appearance in federal court in Boston on Sept. 9, 2026.
According to the charging documents, while working as a licensed pharmacist at a national pharmacy chain, Bradley allegedly diverted various quantities of Dextroamp-amphetamin for his own use on four occasions in August, September and November 2024. Additionally, on Nov. 10, 2024, Bradley is alleged to have also diverted Adderall. These controlled substances originally were intended for customers.
The charge of acquiring a controlled substance by fraud, deception, and subterfuge provides for a sentence of up to four years in prison, one year of supervised release and a fine of $250,000. Sentences are imposed by a federal district court judge based upon the U.S. Sentencing Guidelines and statutes which govern the determination of a sentence in a criminal case.
United States Attorney Leah B. Foley and Jarod A. Forget, Special Agent in Charge of the Drug Enforcement Administration, New England Field Division made the announcement today. Valuable assistance was provided by the Massachusetts State Police, the Barnstable County Sheriff’s Department and the Barnstable, Harwich, Bourne, Brewster, Sandwich, Falmouth, Mashpee, Yarmouth and Dennis Police Departments. Assistant U.S. Attorney Meghan Cleary of the Health Care Fraud Unit is prosecuting the case.
The details contained in the charging document are allegations. The defendant is presumed to be innocent unless and until proven guilty beyond a reasonable doubt in the court of law.
